Molecular diagnosis of prostate cancer: PCA3 and TMPRSS2:ERG gene fusion.
about
In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urineCurrent status of biomarkers for prostate cancerDistinct genetic alterations in small cell carcinoma from different anatomic sitesAssociation of DSC3 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosisComparative assessment of methods for the fusion transcripts detection from RNA-Seq dataEpithelial mesenchymal transition (EMT) in prostate growth and tumor progressionPredictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence.Potential utility of cancer-specific biomarkers for assessing response to hormonal treatments in metastatic prostate cancer.DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate CancerDownregulation of long noncoding RNA ZMAT1 transcript variant 2 predicts a poor prognosis in patients with gastric cancer.Prostasomes as a source of diagnostic biomarkers for prostate cancer.Genomic and Epigenomic Alterations in CancerInvestigation of the molecular mechanisms underlying metastasis in prostate cancer by gene expression profilingControversies on individualized prostate cancer care: gaps in current practice.The cost implications of prostate cancer screening in the Medicare population.Biomarkers for prostate cancer: present challenges and future opportunities.Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression.miRNAs as biomarkers in prostate cancer.The role of biomarkers in the assessment of prostate cancer risk prior to prostate biopsy: which markers matter and how should they be used?Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis.Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions.Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.c-Myc-regulated long non-coding RNA H19 indicates a poor prognosis and affects cell proliferation in non-small-cell lung cancer.Preliminary Results of Noninvasive Detection of TMPRSS2:ERG Gene Fusion in a Cohort of Patients With Localized Prostate CancerEvaluation of urinary prostate cancer antigen-3 (PCA3) and TMPRSS2-ERG score changes when starting androgen-deprivation therapy with triptorelin 6-month formulation in patients with locally advanced and metastatic prostate cancer.High frequency of the SDK1:AMACR fusion transcript in Chinese prostate cancer.Two-Stage Biomarker Protocols for Improving the Precision of Early Detection of Prostate Cancer.Overexpression of long noncoding RNA PCAT-1 is a novel biomarker of poor prognosis in patients with colorectal cancer.Assays for prostate cancer : changing the screening paradigm?Advancing age within established Gleason score categories and the risk of prostate cancer-specific mortality (PCSM).Nuclear magnetic resonance spectroscopy as a new approach for improvement of early diagnosis and risk stratification of prostate cancer.Low expression of long noncoding RNA GAS6-AS1 predicts a poor prognosis in patients with NSCLC.Future prospects in the diagnosis and management of localized prostate cancer.The crucial role of multiomic approach in cancer research and clinically relevant outcomes.A novel long non-coding RNATCONS_00001798 is downregulated and predicts survival in patients with non-small cell lung cancer.Pathology and molecular updates in tumors of the prostate: towards a personalized approach.Long noncoding RNA GAS5 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer.Rational basis for the combination of PCA3 and TMPRSS2:ERG gene fusion for prostate cancer diagnosis.c-Myc-induced, long, noncoding H19 affects cell proliferation and predicts a poor prognosis in patients with gastric cancer.Cost implications of PSA screening differ by age.
P2860
Q24337415-D9C26595-FE54-4CB5-84A4-449A65C77818Q24600574-99C37A98-7FC7-4960-9A89-D01BBD8513DFQ27008242-E188B69B-DEC8-4F9E-8D10-856A613F8BF2Q28541425-927606C5-288D-4D8B-87D4-D1FD44B1EC5AQ30277371-8E08ED4A-AF9E-444F-8F9A-3106875FF55DQ34397291-01F7BDB2-1609-42B9-B35C-FC5E8CA56FB5Q34427649-E34425D7-A98D-467A-92DE-4D2C7E3932C3Q34536729-962B1F83-B07A-4134-93AF-5E8005292363Q35667011-16A332D8-B66D-4E6E-A8D9-6519188017A6Q35854266-9EC0BCEF-D5D6-4A37-ADDD-CF91C303EF2AQ36737927-66B860CA-3E90-4585-8F99-12C2538D0126Q37057145-914D2320-7238-4C4A-8394-1F73DC88F0D7Q37108412-9A4C9BE5-6BE2-4A06-9084-13F7AC91C00EQ37149085-E058DB22-2F54-40C8-94E1-A80B86CA7AB6Q37402386-0C13C49D-EBAC-459B-95B5-D16911805562Q37474443-021FD2F8-24CE-4AA3-9369-2D654D3B8D64Q37672628-C5E02E46-0BF1-4F34-9A81-7CE9B0DF6F9CQ38031424-38290508-B419-4CBA-9D4A-2F33FF17D72EQ38211603-21BAAA7E-B2E9-4358-80BE-C2B4D7FC2E14Q38268839-356AB3E0-A75E-464E-87DE-424C4A9E7DE1Q38786630-97CCE41E-EAE8-4E09-92AD-325F010393D5Q40281409-27CA1913-463E-4CF9-99C1-980F80DF888DQ41201794-1674F507-B75A-4176-B8BE-C8A1C70B42FBQ41896226-C822761C-5AB4-45B1-839B-01A594DBC198Q42659330-CFEF705F-7EE4-430B-8CD3-C76981D547CBQ43156871-079C7C5E-6E76-4115-ADAF-68E4E2BD238AQ44871406-CF5EB4C7-929C-4011-AEE4-75E0353F7CA7Q46275729-D8A8B6D9-CA06-4950-AD34-798ECE1E429FQ46530327-42DC99F6-29A3-4FEF-B354-FA38226E124DQ46790909-7887EA84-76E9-4BBE-BA9F-6E24D4C6FCB4Q47110549-5A8623DB-045F-4822-9DC4-36141BCFAE43Q47693376-7628CF61-FB11-4842-8AFB-2E658EDEC0B8Q51348320-8ACDF025-5164-48AC-B9CE-093E2BD9ACC9Q52363678-1A3263AD-C7C5-4EB6-9723-E546EC0F5657Q52643616-5D34EEBD-7883-4C8A-A95D-CD7B1675E17AQ52861100-B24E3E93-E49B-402A-9CCE-6FAFC1B55156Q53229252-48CA230B-3C00-4888-B1BC-C3FCD299855FQ53801746-95A16446-98E8-4ACB-9B5C-2C337605B359Q54216111-DFFBEFCD-539B-4FB4-8DF9-F9670A98B05FQ55032029-E5758899-7ACC-4E58-9E80-083211590A20
P2860
Molecular diagnosis of prostate cancer: PCA3 and TMPRSS2:ERG gene fusion.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Molecular diagnosis of prostate cancer: PCA3 and TMPRSS2:ERG gene fusion.
@en
Molecular diagnosis of prostate cancer: PCA3 and TMPRSS2:ERG gene fusion.
@nl
type
label
Molecular diagnosis of prostate cancer: PCA3 and TMPRSS2:ERG gene fusion.
@en
Molecular diagnosis of prostate cancer: PCA3 and TMPRSS2:ERG gene fusion.
@nl
prefLabel
Molecular diagnosis of prostate cancer: PCA3 and TMPRSS2:ERG gene fusion.
@en
Molecular diagnosis of prostate cancer: PCA3 and TMPRSS2:ERG gene fusion.
@nl
P1476
Molecular diagnosis of prostate cancer: PCA3 and TMPRSS2:ERG gene fusion.
@en
P2093
Jack A Schalken
Maciej Salagierski
P304
P356
10.1016/J.JURO.2011.10.133
P407
P577
2012-01-15T00:00:00Z